What they were paid
Immix Biopharma Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $47,500 | $0 | $53,496 | $0 | $100,996 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immix Biopharma, Inc. DEF 14A filed April 6, 2026, accession 0001493152-26-015320, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Immix Biopharma pays directors a $40,000 cash retainer and $80,000 in Options.
Committees
FY2025 · as the proxy prints themAudit
The rest of the Immix Biopharma board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Gabriel Morris | Director | $0 |
| Helen C. Adams | Lead Independent Director | $125,996 |
| Ilya Rachman | Chair of the Board | $0 |
| Jane Buchan | Independent Director | $113,996 |
| Jason Hsu | Independent Director | $97,496 |
| Magda Marquet | Independent Director | $107,496 |
| Nancy Chang | Director | $458,197 |
| Yekaterina Chudnovsky | Independent Director | $95,496 |
The full Immix Biopharma compensation record
free company briefThis page is one director within Immix Biopharma's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat